{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:58:34Z","timestamp":1793735914959,"version":"4.6.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cca.2026.121063","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:24:23Z","timestamp":1778167463000},"page":"121063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Thrombosis at the crossroads of inflammation, coagulation, and vascular biology: Recent advances and emerging therapeutic strategies"],"prefix":"10.1016","volume":"590","author":[{"given":"Madan Gopal","family":"Ramarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Reda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherief","family":"Ghozy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasantha","family":"Ranatunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanathan","family":"Kadirvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.cca.2026.121063_bb0005","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.103.13.1718","article-title":"Inflammation and thrombosis: the clot thickens","volume":"103","author":"Libby","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cca.2026.121063_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.blre.2009.07.002","article-title":"Basic mechanisms and pathogenesis of venous thrombosis","volume":"23","author":"Esmon","year":"2009","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11239-015-1308-1","article-title":"Guidance for the management of venous thrombosis in unusual sites","volume":"41","author":"Ageno","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: burden, mechanisms, and management","volume":"117","author":"Ay","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"10244","key":"10.1016\/j.cca.2026.121063_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(20)31179-X","article-title":"Stroke","volume":"396","author":"Campbell","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cca.2026.121063_bb0030","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.thromres.2014.08.014","article-title":"Thrombosis: a major contributor to global disease burden","volume":"134","year":"2014","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.cca.2026.121063_bb0035","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2026.121063_bb0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/asheducation.V2012.1.626.3798655","article-title":"Cancer-associated thrombosis: updates and controversies","volume":"2012","author":"Khorana","year":"2012","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"6","key":"10.1016\/j.cca.2026.121063_bb0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-0035-1556732","article-title":"The activation of complement and its role in the pathogenesis of thromboembolism","volume":"41","author":"Boyce","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"issue":"3\u20134","key":"10.1016\/j.cca.2026.121063_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3121\/cmr.2009.866","article-title":"Virchow\u2019s contribution to the understanding of thrombosis and cellular biology","volume":"8","author":"Kumar","year":"2010","journal-title":"Clin. Med. Res."},{"issue":"7","key":"10.1016\/j.cca.2026.121063_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.32000\/2072-1757-2022-7-8-12","article-title":"Mechanisms of coagulopathy in COVID-19","volume":"20","author":"Khaertynov","year":"2022","journal-title":"Practical Med."},{"issue":"8","key":"10.1016\/j.cca.2026.121063_bb0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/s-0031-1297375","article-title":"Microvascular thrombosis: a serious and deadly pathologic process in multiple diseases","volume":"37","author":"Kwaan","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.carj.2014.11.001","article-title":"Multimodality imaging of tumour Thrombus","volume":"66","author":"Rohatgi","year":"2015","journal-title":"Can. Assoc. Radiol. J."},{"issue":"12","key":"10.1016\/j.cca.2026.121063_bb0070","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood-2004-03-1107","article-title":"beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome","volume":"104","author":"de Laat","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cca.2026.121063_bb0075","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cca.2026.121063_bb0080","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.cca.2026.121063_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/HAB-2003-12301","article-title":"Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome","volume":"12","author":"Marai","year":"2003","journal-title":"Hum. Antibodies"},{"issue":"8","key":"10.1016\/j.cca.2026.121063_bb0090","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/ard.50.8.548","article-title":"Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus","volume":"50","author":"McHugh","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2026.121063_bb0095","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fimmu.2019.00376","article-title":"Reliability of lupus anticoagulant and anti-phosphatidylserine\/prothrombin autoantibodies in antiphospholipid syndrome: a Multicenter study","volume":"10","author":"Sciascia","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121063_bb0100","doi-asserted-by":"crossref","first-page":"1527554","DOI":"10.3389\/fimmu.2025.1527554","article-title":"Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121063_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2018.02.002","article-title":"Beyond thrombosis: anti-beta2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome","volume":"90","author":"Chighizola","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2026.121063_bb0110","article-title":"Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: an experience","volume":"10","author":"Hegde","year":"2022","journal-title":"SAGE Open Med. Case Rep."},{"issue":"216","key":"10.1016\/j.cca.2026.121063_bb0115","first-page":"133","article-title":"A simplified understanding of the black swan: anti-phospholipid antibody syndrome","volume":"57","author":"Vaidya","year":"2019","journal-title":"JNMA J. Nepal Med. Assoc."},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021331","article-title":"Hydroxychloroquine as an immunomodulatory and antithrombotic treatment in antiphospholipid syndrome","volume":"24","author":"Arachchillage","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.cca.2026.121063_bb0125","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","article-title":"Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics","volume":"69","author":"Corban","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0049-3848(89)90447-7","article-title":"Heparin-induced thrombocytopenia: effects of rabbit IgG, and its fab and FC fragments on antibody-heparin-platelet interaction","volume":"55","author":"Chong","year":"1989","journal-title":"Thromb. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2026.121063_bb0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ijlh.13564","article-title":"Diagnosing heparin-induced thrombocytopenia: the need for accuracy and speed","volume":"43","author":"Pishko","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"issue":"6","key":"10.1016\/j.cca.2026.121063_bb0140","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2005-08-3122","article-title":"Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications","volume":"107","author":"Rauova","year":"2006","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.cca.2026.121063_bb0145","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood-2014-03-559518","article-title":"Binding of anti-platelet factor 4\/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4","volume":"124","author":"Kreimann","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121063_bb0150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/asheducation-2013.1.668","article-title":"Heparin-induced thrombocytopenia","volume":"2013","author":"Lee","year":"2013","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"4","key":"10.1016\/j.cca.2026.121063_bb0155","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1160\/TH11-11-0795","article-title":"Disruption of PF4\/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH)","volume":"107","author":"Joglekar","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"7873","key":"10.1016\/j.cca.2026.121063_bb0160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0165","article-title":"Epidemiology of prothrombin G20210A mutation in the Mediterranean region","volume":"3","author":"Jadaon","year":"2011","journal-title":"Mediterr J. Hematol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181faa0f2","article-title":"Factor V Leiden thrombophilia","volume":"13","author":"Kujovich","year":"2011","journal-title":"Genet. Med."},{"issue":"8","key":"10.1016\/j.cca.2026.121063_bb0175","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0036-1592333","article-title":"Environmental and genetic risk factors associated with venous thromboembolism","volume":"42","author":"Crous-Bou","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"issue":"12","key":"10.1016\/j.cca.2026.121063_bb0180","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1182\/blood.2019000049","article-title":"Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of alpha2-antiplasmin","volume":"134","author":"Singh","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cca.2026.121063_bb0185","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/s-0037-1613085","article-title":"Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium","volume":"87","author":"Martinelli","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.cca.2026.121063_bb0190","doi-asserted-by":"crossref","first-page":"1220 e17","DOI":"10.1016\/j.amjmed.2017.05.026","article-title":"Do factor V Leiden and prothrombin G20210A mutations predict recurrent venous thromboembolism in older patients?","volume":"130","author":"Mean","year":"2017","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.cca.2026.121063_bb0195","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","article-title":"Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients","volume":"122","author":"Geddings","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cca.2026.121063_bb0200","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1055\/s-0035-1564040","article-title":"Cancer tissue procoagulant mechanisms and the hypercoagulable state of patients with Cancer","volume":"41","author":"Falanga","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.cca.2026.121063_bb0205","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3892\/ijo.2017.4172","article-title":"Differential contribution of tissue factor and factor XII to thrombin generation triggered by breast and pancreatic cancer cells","volume":"51","author":"Rousseau","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cca.2026.121063_bb0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/PROM.S10099","article-title":"Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival","volume":"2","author":"Falanga","year":"2011","journal-title":"Patient Relat Outcome Meas"},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001721-199703000-00001","article-title":"Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue","volume":"8","author":"Gordon","year":"1997","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0220","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ijc.28997","article-title":"Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo","volume":"136","author":"Mezouar","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cca.2026.121063_bb0225","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13046-016-0328-9","article-title":"Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients","volume":"35","author":"Zhao","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12964-023-01110-7","article-title":"Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders","volume":"21","author":"Ben","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"7","key":"10.1016\/j.cca.2026.121063_bb0235","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1158\/1541-7786.MCR-19-1041","article-title":"Urothelial carcinoma of the bladder induces endothelial cell activation and hypercoagulation","volume":"18","author":"John","year":"2020","journal-title":"Mol. Cancer Res."},{"issue":"16","key":"10.1016\/j.cca.2026.121063_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612585","article-title":"SARS-CoV-2 spike proteins and cell-cell communication induce P-selectin and markers of endothelial injury, NETosis, and inflammation in human lung microvascular endothelial cells and neutrophils: implications for the pathogenesis of COVID-19 coagulopathy","volume":"24","author":"Bhargavan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0245","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11239-021-02583-4","article-title":"Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy","volume":"53","author":"Cacciola","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"issue":"12","key":"10.1016\/j.cca.2026.121063_bb0250","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","article-title":"The coagulopathy, endotheliopathy, and vasculitis of COVID-19","volume":"69","author":"Iba","year":"2020","journal-title":"Inflamm. Res."},{"issue":"10","key":"10.1016\/j.cca.2026.121063_bb0255","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1002\/bjs.11904","article-title":"Acute peripheral arterial thrombosis in COVID-19. Role of endothelial inflammation","volume":"107","author":"Gonzalez Canas","year":"2020","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0260","doi-asserted-by":"crossref","first-page":"20230724","DOI":"10.1515\/med-2023-0724","article-title":"Saddle pulmonary embolism in the setting of COVID-19 infection: a systematic review of case reports and case series","volume":"18","author":"Choudry","year":"2023","journal-title":"Open Med. (Wars)"},{"key":"10.1016\/j.cca.2026.121063_bb0265","article-title":"Inflammation-induced coagulopathy substantially differs between COVID-19 and septic shock: a prospective observational study","volume":"8","author":"Dechamps","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0270","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12959-021-00304-8","article-title":"Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19","volume":"19","author":"Advani","year":"2021","journal-title":"Thromb J."},{"issue":"12","key":"10.1016\/j.cca.2026.121063_bb0275","doi-asserted-by":"crossref","first-page":"92","DOI":"10.22159\/ajpcr.2022.v15i12.46338","article-title":"STUDY OF D-DIMER AND SERUM FERRITIN LEVELS AS PROGNOSTIC BIOMARKERS IN COVID-19 PATIENTS","volume":"15","author":"Sogani","year":"2022","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"10.1016\/j.cca.2026.121063_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.779453","article-title":"Inflammation and platelet activation after COVID-19 vaccines - possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis","volume":"12","author":"Ostrowski","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2026.121063_bb0285","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/107602960000600312","article-title":"Rapid genetic diagnosis in neonatal pulmonary artery thrombosis caused by homozygous antithrombin Budapest 3","volume":"6","author":"Brown","year":"2000","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"9","key":"10.1016\/j.cca.2026.121063_bb0290","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1538-7836.2012.04858.x","article-title":"Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism","volume":"10","author":"Bucciarelli","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.cca.2026.121063_bb0295","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/17474086.2020.1804354","article-title":"Genetic risk factors for venous thromboembolism","volume":"13","author":"Zoller","year":"2020","journal-title":"Expert Rev. Hematol."},{"issue":"12","key":"10.1016\/j.cca.2026.121063_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.8280","article-title":"The c.1243T>C mutation in the PROC gene is linked with inherited protein C deficiency and severe purpura fulminans","volume":"11","author":"Nourbakhsh","year":"2023","journal-title":"Clin. Case Reports"},{"issue":"9","key":"10.1016\/j.cca.2026.121063_bb0305","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0310","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MBC.0b013e32834ddefd","article-title":"New quantitative total protein S-assay system for diagnosing protein S type II deficiency: clinical application of the screening system for protein S type II deficiency","volume":"23","author":"Tsuda","year":"2012","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.cca.2026.121063_bb0315","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/5584_2016_120","article-title":"Genetic risk factors in venous thromboembolism","volume":"906","author":"Hotoleanu","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.cca.2026.121063_bb0320","doi-asserted-by":"crossref","DOI":"10.47611\/jsrhs.v11i3.3165","article-title":"Factors contributing to the risk of venous thromboembolism","volume":"11","author":"Chen","year":"2022","journal-title":"J. Student Res."},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0325","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3329\/jdmc.v30i2.56931","article-title":"Cerebral venous sinus thrombosis with hereditary antithrombin iii deficiency after COVID-19 vaccination: a case report","volume":"30","author":"Sayeed","year":"2023","journal-title":"J Dhaka Med. College"},{"key":"10.1016\/j.cca.2026.121063_bb0330","article-title":"Immune mechanisms of plaque instability","volume":"8","author":"Gerhardt","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.cca.2026.121063_bb0335","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.cca.2026.121063_bb0340","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1753944710375780","article-title":"Antiplatelet therapy and vascular disease: an update","volume":"4","author":"Buch","year":"2010","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0345","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCRESAHA.117.310694","article-title":"Flow perturbation mediates neutrophil recruitment and potentiates endothelial injury via TLR2 in mice: implications for superficial Erosion","volume":"121","author":"Franck","year":"2017","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.cca.2026.121063_bb0350","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/jth.13369","article-title":"C-reactive protein, obesity, and the risk of arterial and venous thrombosis","volume":"14","author":"Horvei","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0355","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"3","key":"10.1016\/j.cca.2026.121063_bb0360","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0034-1370765","article-title":"NETosis: a new factor in tumor progression and cancer-associated thrombosis","volume":"40","author":"Demers","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"issue":"9","key":"10.1016\/j.cca.2026.121063_bb0365","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/CIRCRESAHA.120.315931","article-title":"Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights","volume":"126","author":"Doring","year":"2020","journal-title":"Circ. Res."},{"issue":"36","key":"10.1016\/j.cca.2026.121063_bb0370","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.cca.2026.121063_bb0375","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2009-05-199208","article-title":"Coagulation and innate immune responses: can we view them separately?","volume":"114","author":"Delvaeye","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0380","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24993","article-title":"Neutrophil extracellular traps in ischemic stroke thrombi","volume":"82","author":"Laridan","year":"2017","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.cca.2026.121063_bb0385","article-title":"Neutrophil extracellular traps in ischemic stroke thrombi are associated Wth poor clinical outcome","volume":"3","author":"Lapostolle","year":"2023","journal-title":"stroke: vascular and interventional Neurology"},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0390","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/s41598-018-20479-x","article-title":"Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA","volume":"8","author":"Dyer","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121063_bb0395","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2018.08.005","article-title":"The role of neutrophils in thrombosis","volume":"170","author":"Kapoor","year":"2018","journal-title":"Thromb. Res."},{"issue":"19","key":"10.1016\/j.cca.2026.121063_bb0400","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2015-08-662650","article-title":"ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice","volume":"127","author":"Denorme","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121063_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132184","article-title":"The clonal hematopoiesis mutation Jak2(V617F) aggravates endothelial injury and thrombosis in arteries with erosion-like intimas","volume":"409","author":"Molinaro","year":"2024","journal-title":"Int. J. Cardiol."},{"issue":"19","key":"10.1016\/j.cca.2026.121063_bb0410","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180066","article-title":"Clonal hematopoiesis and atherosclerosis","volume":"134","author":"Oren","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.cca.2026.121063_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251810208","article-title":"Role of gut microbial metabolites in cardiovascular diseases-current insights and the road ahead","volume":"25","author":"Datta","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.cca.2026.121063_bb0420","article-title":"Role of gut microbiome in cardiovascular events: a systematic review","volume":"14","author":"Mansuri","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.cca.2026.121063_bb0425","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.17185","article-title":"Atherosclerosis, gut microbiome, and exercise in a meta-omics perspective: a literature review","volume":"12","author":"Tang","year":"2024","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0430","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0435","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12959-023-00514-2","article-title":"Circulating LPS from gut microbiota leverages stenosis-induced deep vein thrombosis in mice","volume":"21","author":"Liu","year":"2023","journal-title":"Thromb. J."},{"issue":"12","key":"10.1016\/j.cca.2026.121063_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7120691","article-title":"The gut microbiota in cardiovascular disease and arterial thrombosis","volume":"7","author":"Lassiger-Herfurth","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.cca.2026.121063_bb0445","doi-asserted-by":"crossref","DOI":"10.37349\/emed.2025.1001339","article-title":"TMAO metaorganismal pathway and chronic inflammatory diseases","volume":"6","author":"Wang Z","year":"2025","journal-title":"Explor. Med."},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0450","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1160\/TH10-05-0307","article-title":"Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis","volume":"105","author":"Salomon","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"10333","key":"10.1016\/j.cca.2026.121063_bb0455","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(22)00456-1","article-title":"Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study","volume":"399","author":"Piccini","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0460","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet-collagen interaction: is GPVI the central receptor?","volume":"102","author":"Nieswandt","year":"2003","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.cca.2026.121063_bb0465","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.110.980623","article-title":"Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans","volume":"123","author":"Ungerer","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cca.2026.121063_bb0470","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1405760","article-title":"Factor XI antisense oligonucleotide for prevention of venous thrombosis","volume":"372","author":"Buller","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.cca.2026.121063_bb0475","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00018-015-1845-y","article-title":"Platelet-neutrophil interactions under thromboinflammatory conditions","volume":"72","author":"Li","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.cca.2026.121063_bb0545","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa2105872","article-title":"Abelacimab for prevention of venous thromboembolism","volume":"385","author":"Verhamme","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.cca.2026.121063_bb0555","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1161\/STROKEAHA.121.037006","article-title":"Revacept, an inhibitor of platelet adhesion in symptomatic carotid stenosis: a Multicenter randomized phase II trial","volume":"53","author":"Uphaus","year":"2022","journal-title":"Stroke"},{"issue":"28","key":"10.1016\/j.cca.2026.121063_bb0560","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100561118","article-title":"DNAse-dependent, NET-independent pathway of thrombus formation in vivo","volume":"118","author":"Carminita","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.cca.2026.121063_bb0565","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/jth.15313","article-title":"PAD4 takes charge during neutrophil activation: impact of PAD4 mediated NET formation on immune-mediated disease","volume":"19","author":"Liu","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.cca.2026.121063_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111318","article-title":"Deep learning model for diagnosis of venous thrombosis from lower extremity peripheral ultrasound imaging","volume":"27","author":"Chen","year":"2024","journal-title":"iScience"},{"issue":"10063","key":"10.1016\/j.cca.2026.121063_bb0485","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","article-title":"Deep vein thrombosis and pulmonary embolism","volume":"388","author":"Di Nisio","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0490","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11307-024-01973-3","article-title":"First-in-human evaluation of safety and dosimetry of [(64)cu]FBP8: a fibrin-binding PET probe","volume":"27","author":"Izquierdo-Garcia","year":"2025","journal-title":"Mol. Imaging Biol."},{"issue":"4","key":"10.1016\/j.cca.2026.121063_bb0495","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1039\/D1LC00981H","article-title":"Point-of-care blood coagulation assay enabled by printed circuit board-based digital microfluidics","volume":"22","author":"Li","year":"2022","journal-title":"Lab Chip"},{"issue":"3","key":"10.1016\/j.cca.2026.121063_bb0500","first-page":"226","article-title":"Microparticles and cardiovascular disease","volume":"98","author":"Morel","year":"2005","journal-title":"Arch. Mal. Coeur Vaiss."},{"issue":"7","key":"10.1016\/j.cca.2026.121063_bb0505","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1538-7836.2008.02981.x","article-title":"D-dimer for venous thromboembolism diagnosis: 20 years later","volume":"6","author":"Righini","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0510","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21037\/qims-21-140","article-title":"Clot burden of acute pulmonary thromboembolism: comparison of two deep learning algorithms, Qanadli score, and Mastora score","volume":"12","author":"Zhang","year":"2022","journal-title":"Quant Imaging Med Surg"},{"issue":"5","key":"10.1016\/j.cca.2026.121063_bb0570","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/jama.2025.21561","article-title":"Age-adjusted D-dimer Cutoff levels to rule out deep vein thrombosis","volume":"335","author":"Le Gal","year":"2026","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cca.2026.121063_bb0575","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/jama.2025.23182","article-title":"Like a fine wine-aging the D-dimer to improve value and clinical efficiency","volume":"335","author":"Ujueta","year":"2026","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.cca.2026.121063_bb0580","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1158\/1078-0432.CCR-09-0371","article-title":"Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy","volume":"15","author":"Zwicker","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cca.2026.121063_bb0585","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cyto.a.22647","article-title":"Microparticle analysis in disorders of hemostasis and thrombosis","volume":"89","author":"Mooberry","year":"2016","journal-title":"Cytometry A"},{"issue":"7","key":"10.1016\/j.cca.2026.121063_bb0590","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2967\/jnumed.115.157982","article-title":"Radiation dosimetry of the fibrin-binding probe (6)(4)cu-FBP8 and its feasibility for PET imaging of deep vein thrombosis and pulmonary embolism in rats","volume":"56","author":"Blasi","year":"2015","journal-title":"J. Nucl. Med."},{"issue":"10","key":"10.1016\/j.cca.2026.121063_bb0595","article-title":"AI-enhanced deep learning framework for pulmonary embolism detection in CT angiography","volume":"12","author":"Lu","year":"2025","journal-title":"Bioeng. (Basel)"},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0600","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41746-025-01518-0","article-title":"Value of clinical review for AI-guided deep vein thrombosis diagnosis with ultrasound imaging by non-expert operators","volume":"8","author":"Speranza","year":"2025","journal-title":"NPJ Digit. Med."},{"issue":"10","key":"10.1016\/j.cca.2026.121063_bb0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205511","article-title":"Thrombin-antithrombin complex measurement using a point-of-care testing device for diagnosis of disseminated intravascular coagulation in dogs","volume":"13","author":"Rimpo","year":"2018","journal-title":"PloS One"},{"issue":"19","key":"10.1016\/j.cca.2026.121063_bb0610","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1039\/D1LC00465D","article-title":"Point of care whole blood microfluidics for detecting and managing thrombotic and bleeding risks","volume":"21","author":"Diamond","year":"2021","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.cca.2026.121063_bb0615","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.thromres.2015.05.012","article-title":"Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis","volume":"136","author":"Branchford","year":"2015","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.cca.2026.121063_bb0620","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/09537104.2017.1293809","article-title":"Use of microfluidics to assess the platelet-based control of coagulation","volume":"28","author":"Nagy","year":"2017","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.cca.2026.121063_bb0515","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpt.668","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for pharmacogenetics-guided warfarin dosing: 2017 update","volume":"102","author":"Johnson","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"24","key":"10.1016\/j.cca.2026.121063_bb0520","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1310669","article-title":"A pharmacogenetic versus a clinical algorithm for warfarin dosing","volume":"369","author":"Kimmel","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cca.2026.121063_bb0525","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2217\/pme-2017-0092","article-title":"Pharmacogenetics of novel oral anticoagulants: a review of identified gene variants & future perspectives","volume":"15","author":"Asic","year":"2018","journal-title":"Per Med"},{"issue":"16","key":"10.1016\/j.cca.2026.121063_bb0530","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1182\/blood-2013-12-544692","article-title":"Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics","volume":"123","author":"Simon","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cca.2026.121063_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174944","article-title":"Can machine-learning improve cardiovascular risk prediction using routine clinical data?","volume":"12","author":"Weng","year":"2017","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.cca.2026.121063_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28034","article-title":"Prediction of atrial fibrillation and stroke using machine learning models in UK Biobank","volume":"10","author":"Papadopoulou","year":"2024","journal-title":"Heliyon"},{"issue":"22","key":"10.1016\/j.cca.2026.121063_bb0550","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehv044","article-title":"TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion","volume":"36","author":"Quillard","year":"2015","journal-title":"Eur. Heart J."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:31:15Z","timestamp":1783643475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":124,"alternative-id":["S0009898126002457"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121063","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis at the crossroads of inflammation, coagulation, and vascular biology: Recent advances and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121063"}}